10090116

Source:http://linkedlifedata.com/resource/pubmed/id/10090116

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0007222, umls-concept:C0010181, umls-concept:C0016538, umls-concept:C0063164, umls-concept:C0243077, umls-concept:C0441471, umls-concept:C0679699, umls-concept:C0814225, umls-concept:C1292733, umls-concept:C1522318, umls-concept:C1705117, umls-concept:C1708528, umls-concept:C1880018
pubmed:issue	6
pubmed:dateCreated	1999-4-7
pubmed:abstractText	To forecast the long-term benefits and cost-effectiveness of lipid modification in the secondary prevention of cardiovascular disease.
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/0372440
pubmed:citationSubset	AIM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Hydroxymethylglutaryl-CoA..., http://linkedlifedata.com/resource/pubmed/chemical/Hypolipidemic Agents, http://linkedlifedata.com/resource/pubmed/chemical/Simvastatin
pubmed:status	MEDLINE
pubmed:month	Mar
pubmed:issn	0003-9926
pubmed:author	pubmed-author:CoupalLL, pubmed-author:GroverS ASA, pubmed-author:PaquetSS, pubmed-author:ZowallHH
pubmed:issnType	Print
pubmed:day	22
pubmed:volume	159
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	593-600
pubmed:dateRevised	2010-11-18
pubmed:meshHeading	pubmed-meshheading:10090116-Adult, pubmed-meshheading:10090116-Aged, pubmed-meshheading:10090116-Canada, pubmed-meshheading:10090116-Cardiovascular Diseases, pubmed-meshheading:10090116-Cerebrovascular Disorders, pubmed-meshheading:10090116-Cost-Benefit Analysis, pubmed-meshheading:10090116-Drug Costs, pubmed-meshheading:10090116-Female, pubmed-meshheading:10090116-Humans, pubmed-meshheading:10090116-Hydroxymethylglutaryl-CoA Reductase Inhibitors, pubmed-meshheading:10090116-Hypolipidemic Agents, pubmed-meshheading:10090116-Life Expectancy, pubmed-meshheading:10090116-Male, pubmed-meshheading:10090116-Middle Aged, pubmed-meshheading:10090116-Recurrence, pubmed-meshheading:10090116-Risk, pubmed-meshheading:10090116-Scandinavia, pubmed-meshheading:10090116-Sensitivity and Specificity, pubmed-meshheading:10090116-Simvastatin
pubmed:year	1999
pubmed:articleTitle	Cost-effectiveness of 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors in the secondary prevention of cardiovascular disease: forecasting the incremental benefits of preventing coronary and cerebrovascular events.
pubmed:affiliation	Centre for the Analysis of Cost-Effective Care, Montreal General Hospital, Department of Medicine, McGill University, Quebec.
pubmed:publicationType	Journal Article